ANKYLOSING SPONDYLITIS (AS)
Clinical trials for ANKYLOSING SPONDYLITIS (AS) explained in plain language.
Never miss a new study
Get alerted when new ANKYLOSING SPONDYLITIS (AS) trials appear
Sign up with your email to follow new studies for ANKYLOSING SPONDYLITIS (AS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive korean study confirms Upadacitinib's Real-World safety
Disease control CompletedThis study looked at how safe and effective upadacitinib is for Korean patients with rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Over 2,300 adults took the drug as prescribed by their doctor and were followed for about 28 weeks. Resear…
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Blood sample study explores new target for inflammatory arthritis
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis) and 12 healthy volunteers to understand how a receptor called KIR3DL2 contributes to inflammation. Researchers also tested whether a drug called IPH4102 could reduce …
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study hints Anti-TNF may improve sleep in ankylosing spondylitis
Knowledge-focused CompletedThis study followed 18 adults with active ankylosing spondylitis who were starting anti-TNF therapy for the first time. Researchers measured their sleep quality using overnight sleep tests and a questionnaire, and tracked their daily step counts with a wearable device. The goal w…
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC